Establishment and Validation of a Nomogram Clinical Prediction Model for Nosocomial Candidemia: An 18-Year Retrospective Analysis.

Jingwen Zhang, Guoqiang Zhang, JiaJia Wang, Yun Xiao, Xinxin Lu, Xunhong Lan, Yan Zhang, Zhang Dai
Author Information
  1. Jingwen Zhang: Centre of Clinical Laboratory, Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, People's Republic of China.
  2. Guoqiang Zhang: Centre of Clinical Laboratory, Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, People's Republic of China.
  3. JiaJia Wang: Centre of Clinical Laboratory, Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, People's Republic of China.
  4. Yun Xiao: Centre of Clinical Laboratory, Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, People's Republic of China.
  5. Xinxin Lu: Centre of Clinical Laboratory, Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, People's Republic of China.
  6. Xunhong Lan: Centre of Clinical Laboratory, Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, People's Republic of China.
  7. Yan Zhang: Centre of Clinical Laboratory, Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, People's Republic of China.
  8. Zhang Dai: Centre of Clinical Laboratory, Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, People's Republic of China.

Abstract

Background: Nosocomial candidemia is a life-threatening condition, and the incidence has increased in recent years. Thorough epidemiological data is still lacking in China.
Methods: A retrospective cohort study was conducted to investigate the patients admitted to Zhongshan Hospital Xiamen University from 1 January 2004 to 31 December 2022. This study included 205 individuals who were diagnosed with candidemia as subjects. Additionally, 303 cases with blood cultures were negative during the same period and were from the same department as a control group. We randomly assigned them to the training and validation groups in a 7:3 ratio. The least absolute shrinkage and selection operator regression, univariate and multivariate logistic regression analyses were used to filtrate independent factors associated with nosocomial candidemia. A nomogram model was established based on the selected variables. Receiver operating characteristic (ROC) curve, calibration plots and decision curve analysis (DCA) were used to evaluate clinical utility.
Results: Two hundred and five nosocomial candidemia patients were reported, containing a high proportion of (n = 91,44.39%), followed by (n = 40, 19.51%), (n = 37,18.05%), (n = 23, 11.22%) and (n = 9,4.39%). Multiple organ dysfunction syndrome (OR = 10.372, 95% CI: 4.745-24.14 < 0.001), increased urea nitrogen of serum (OR=1.088,95% CI: 1.039-1.144 <0.001), decreased albumin of serum (OR = 0.922 95% CI: 0.850-0.997 =0.045), mechanical ventilation (OR=4.074,95% CI: 1.397-12.77 =0.012), central venous indwelling catheter (OR=7.422,95% CI: 3.189-18.41 <0.001) and solid tumor (OR = 3.036 95% CI: 1.276-7.359 =0.012) were identified as independent risk factors of candidemia. The area under the curve (AUC) of the nomogram model was 0.925 (95% CI: 0.898-0.952) in the training group and 0.946 (95% CI: 0.881-0.963) in the validation group. The calibration curve revealed good agreement between the probability and the observed values. DCA indicated that this nomogram might be clinically beneficial.
Conclusion: The nomogram including multiple organ dysfunction syndrome, elevated blood urea nitrogen, decreased albumin, mechanical ventilation, central venous indwelling catheter and solid tumor could provide reference value to clinicians for identifying nosocomial candidemia.

Keywords

References

  1. Cancers (Basel). 2023 Nov 24;15(23): [PMID: 38067264]
  2. BMC Infect Dis. 2014 Nov 25;14:609 [PMID: 25420435]
  3. Cancer Immunol Immunother. 2020 Jan;69(1):147-157 [PMID: 31900508]
  4. Am J Respir Crit Care Med. 2018 Aug 1;198(3):361-369 [PMID: 29470918]
  5. Infect Drug Resist. 2022 Aug 26;15:4887-4898 [PMID: 36051656]
  6. Clin Hemorheol Microcirc. 2018;69(1-2):123-131 [PMID: 29758935]
  7. Ann Vasc Surg. 2021 Nov;77:138-145 [PMID: 34428438]
  8. Mycoses. 2020 Nov;63(11):1149-1163 [PMID: 32681527]
  9. J Infect Dis. 2020 May 11;221(11):1907-1916 [PMID: 31879764]
  10. Ann Intensive Care. 2019 Jun 3;9(1):62 [PMID: 31161475]
  11. Clin Infect Dis. 2008 Jun 15;46(12):1813-21 [PMID: 18462102]
  12. PLoS One. 2013;8(3):e59373 [PMID: 23527176]
  13. Pathogens. 2023 Jan 29;12(2): [PMID: 36839484]
  14. Int J Infect Dis. 2012 Jun;16(6):e442-7 [PMID: 22486857]
  15. J Infect Dis. 2010 May 1;201(9):1436-40 [PMID: 20331379]
  16. PLoS One. 2022 Feb 3;17(2):e0263522 [PMID: 35113972]
  17. Antimicrob Resist Infect Control. 2020 Apr 7;9(1):50 [PMID: 32264966]
  18. Intern Emerg Med. 2018 Mar;13(2):199-204 [PMID: 29322386]
  19. AIMS Microbiol. 2023 May 11;9(3):467-485 [PMID: 37649801]
  20. MMWR Surveill Summ. 2019 Sep 27;68(8):1-15 [PMID: 31557145]
  21. Pediatr Infect Dis J. 2021 Nov 1;40(11):981-986 [PMID: 34108407]
  22. Crit Care. 2020 Mar 18;24(1):109 [PMID: 32188500]
  23. Eur Rev Med Pharmacol Sci. 2024 Mar;28(6):2558-2568 [PMID: 38567615]
  24. Ann Intensive Care. 2020 Oct 16;10(1):142 [PMID: 33064220]
  25. Drug Deliv Transl Res. 2021 Aug;11(4):1568-1585 [PMID: 33469892]
  26. Curr Res Microb Sci. 2022 Nov 17;3:100175 [PMID: 36518176]
  27. Int Ophthalmol. 2023 Oct;43(10):3717-3724 [PMID: 37395904]
  28. J Fungi (Basel). 2023 Jan 26;9(2): [PMID: 36836279]
  29. Value Health Reg Issues. 2020 May;21:53-58 [PMID: 31648147]
  30. J Korean Med Sci. 2010 May;25(5):671-6 [PMID: 20436700]
  31. J Clin Med. 2020 Dec 18;9(12): [PMID: 33353113]
  32. Antibiotics (Basel). 2022 Aug 03;11(8): [PMID: 36009922]
  33. Mycoses. 2021 Jul;64(7):753-762 [PMID: 33786895]
  34. Antimicrob Agents Chemother. 2010 Aug;54(8):3149-54 [PMID: 20498325]
  35. Clin Infect Dis. 2009 Jun 15;48(12):1695-703 [PMID: 19441981]
  36. Virulence. 2020 Dec;11(1):1453-1465 [PMID: 33108253]
  37. Mycoses. 2020 Dec;63(12):1373-1381 [PMID: 32885534]
  38. Clin Infect Dis. 2010 Sep 1;51(5):e38-45 [PMID: 20636126]
  39. Mycoses. 2019 Jul;62(7):554-561 [PMID: 31025417]
  40. Med Mycol. 2016 Aug 1;54(6):557-66 [PMID: 27001670]
  41. J Infect. 2011 Sep;63(3):207-14 [PMID: 21777616]
  42. Mycoses. 2024 Mar;67(3):e13717 [PMID: 38544313]

Word Cloud

Created with Highcharts 10.0.0=95%CI:candidemia0nomogramcurven1groupfactorsnosocomialmodelOR001=0NosocomialincreasedstudypatientsbloodtrainingvalidationregressionusedindependentROCcalibrationDCA39%4organdysfunctionsyndromeureanitrogenserum<0decreasedalbuminmechanicalventilation012centralvenousindwellingcatheter3solidtumorriskBackground:life-threateningconditionincidencerecentyearsThoroughepidemiologicaldatastilllackingChinaMethods:retrospectivecohortconductedinvestigateadmittedZhongshanHospitalXiamenUniversityJanuary200431December2022included205individualsdiagnosedsubjectsAdditionally303casesculturesnegativeperioddepartmentcontrolrandomlyassignedgroups7:3ratioleastabsoluteshrinkageselectionoperatorunivariatemultivariatelogisticanalysesfiltrateassociatedestablishedbasedselectedvariablesReceiveroperatingcharacteristicplotsdecisionanalysisevaluateclinicalutilityResults:Twohundredfivereportedcontaininghighproportion9144followed401951%371805%231122%9Multiple10372745-2414<OR=1088039-1144922850-0997045OR=4074397-1277OR=7422189-1841036276-7359identifiedareaAUC925898-0952946881-0963revealedgoodagreementprobabilityobservedvaluesindicatedmightclinicallybeneficialConclusion:includingmultipleelevatedprovidereferencevaluecliniciansidentifyingEstablishmentValidationNomogramClinicalPredictionModelCandidemia:18-YearRetrospectiveAnalysis

Similar Articles

Cited By